Since previous studies showed IL-4 dysregulation in MPN patients and early and late stages of AMD patients, we compared serum cytokine levels between MPNd, MPNn, iAMD and nAMD (Table 2). The gene discussed is IL4; the disease is myeloproliferative neoplasm.